Acute myeloblastic leukaemia, Bone marrow transplantation, Cytarabine
dx.doi.org/10.1046/j.1365-2141.2000.02178.x, hdl.handle.net/1765/65905
British Journal of Haematology
Department of Hematology

Cahn, J.-Y, Labopin, M, Sierra, J, Blaise, D, Reiffers, J, Ferrant, A, … Gorin, N.-C. (2000). No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. British Journal of Haematology, 110(2), 308–314. doi:10.1046/j.1365-2141.2000.02178.x